Do analysts prefer TRAK or LPSN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReposiTrak 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend LPSN or DVLT?

Datavault AI has a consensus price target of $2.50, indicating a potential upside of 1,482.28%. Given Datavault AI's stronger consensus rating and higher probable upside, analysts clearly believe Datavault AI is more favorable than LivePerson. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Datavault AI 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better valuation & earnings, LPSN or DVLT?

LivePerson has higher revenue and earnings than Datavault AI. Datavault AI is trading at a lower price-to-earnings ratio than LivePerson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivePerson $228.89M 0.17 -$67.23M -$13.74 N/A Datavault AI $39.09M 3.84 -$78.99M -$0.42 N/A

Do analysts rate LPSN or ZSQR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Coeptis Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate EGAN or LPSN?

eGain currently has a consensus price target of $6.50, indicating a potential upside of 8.88%. Given eGain's stronger consensus rating and higher possible upside, equities analysts clearly believe eGain is more favorable than LivePerson. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eGain 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, EGAN or LPSN?

eGain has higher earnings, but lower revenue than LivePerson. LivePerson is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio eGain $91.14M 1.71 $8.88M $0.32 18.66 LivePerson $228.89M 0.17 -$67.23M -$13.74 N/A

Is EGAN or LPSN more profitable?

eGain has a net margin of 9.74% compared to LivePerson's net margin of -51.89%. eGain's return on equity of 11.75% beat LivePerson's return on equity. Company Net Margins Return on Equity Return on Assets eGain 9.74% 11.75% 7.06% LivePerson -51.89% N/A -8.39%

Do analysts recommend LPSN or BVC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivePerson 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bitventures 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, LPSN or BVC?

Bitventures has lower revenue, but higher earnings than LivePerson. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LivePerson $228.89M 0.17 -$67.23M -$13.74 N/A Bitventures $28.02M 3.34 -$5.37M N/A N/A

Is LPSN or BVC more profitable?

Bitventures has a net margin of 0.00% compared to LivePerson's net margin of -51.89%. Company Net Margins Return on Equity Return on Assets LivePerson -51.89% N/A -8.39% Bitventures N/A N/A N/A

LivePerson (LPSN) Competitors

$3.10 0.00 (0.00%)

As of 10/1/2026

Compare

LPSN vs. TRAK, DVLT, ZSQR, EGAN, and BVC

Should you buy LivePerson stock or one of its competitors? LivePerson's main competitors and comparable companies include ReposiTrak (TRAK), Datavault AI (DVLT), Coeptis Therapeutics (ZSQR), eGain (EGAN), and Bitventures (BVC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does LivePerson compare to ReposiTrak?

ReposiTrak (NYSE:TRAK) and LivePerson (NASDAQ:LPSN) are both small-cap technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

ReposiTrak has a net margin of 32.51% compared to LivePerson's net margin of -51.89%. ReposiTrak's return on equity of 14.94% beat LivePerson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ReposiTrak	32.51%	14.94%	13.16%
LivePerson	-51.89%	N/A	-8.39%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ReposiTrak	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, ReposiTrak had 13 more articles in the media than LivePerson. MarketBeat recorded 13 mentions for ReposiTrak and 0 mentions for LivePerson. ReposiTrak's average media sentiment score of 0.35 beat LivePerson's score of 0.00 indicating that ReposiTrak is being referred to more favorably in the media.

Company	Overall Sentiment
ReposiTrak	Neutral
LivePerson	Neutral

27.4% of ReposiTrak shares are held by institutional investors. Comparatively, 79.8% of LivePerson shares are held by institutional investors. 41.0% of ReposiTrak shares are held by insiders. Comparatively, 2.0% of LivePerson shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ReposiTrak has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market. Comparatively, LivePerson has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market.

ReposiTrak has higher earnings, but lower revenue than LivePerson. LivePerson is trading at a lower price-to-earnings ratio than ReposiTrak, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ReposiTrak	$23.29M	6.33	$6.98M	$0.39	20.77
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A

Summary

ReposiTrak beats LivePerson on 11 of the 14 factors compared between the two stocks.

How does LivePerson compare to Datavault AI?

LivePerson (NASDAQ:LPSN) and Datavault AI (NASDAQ:DVLT) are both small-cap technology companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

In the previous week, Datavault AI had 25 more articles in the media than LivePerson. MarketBeat recorded 25 mentions for Datavault AI and 0 mentions for LivePerson. LivePerson's average media sentiment score of 0.00 equaled Datavault AI'saverage media sentiment score.

Company	Overall Sentiment
LivePerson	Neutral
Datavault AI	Neutral

79.8% of LivePerson shares are owned by institutional investors. Comparatively, 0.7% of Datavault AI shares are owned by institutional investors. 2.0% of LivePerson shares are owned by insiders. Comparatively, 7.7% of Datavault AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LivePerson has higher revenue and earnings than Datavault AI. Datavault AI is trading at a lower price-to-earnings ratio than LivePerson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A
Datavault AI	$39.09M	3.84	-$78.99M	-$0.42	N/A

LivePerson has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, Datavault AI has a beta of 0.33, suggesting that its share price is 67% less volatile than the broader market.

Datavault AI has a consensus price target of $2.50, indicating a potential upside of 1,482.28%. Given Datavault AI's stronger consensus rating and higher probable upside, analysts clearly believe Datavault AI is more favorable than LivePerson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Datavault AI	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

LivePerson has a net margin of -51.89% compared to Datavault AI's net margin of -370.21%. LivePerson's return on equity of 0.00% beat Datavault AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivePerson	-51.89%	N/A	-8.39%
Datavault AI	-370.21%	-46.04%	-39.35%

Summary

LivePerson and Datavault AI tied by winning 8 of the 16 factors compared between the two stocks.

How does LivePerson compare to Coeptis Therapeutics?

LivePerson (NASDAQ:LPSN) and Coeptis Therapeutics (NASDAQ:ZSQR) are both small-cap technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Coeptis Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LivePerson has a net margin of -51.89% compared to Coeptis Therapeutics' net margin of -773.72%. LivePerson's return on equity of 0.00% beat Coeptis Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivePerson	-51.89%	N/A	-8.39%
Coeptis Therapeutics	-773.72%	-49.45%	-46.88%

In the previous week, Coeptis Therapeutics had 1 more articles in the media than LivePerson. MarketBeat recorded 1 mentions for Coeptis Therapeutics and 0 mentions for LivePerson. LivePerson's average media sentiment score of 0.00 equaled Coeptis Therapeutics'average media sentiment score.

Company	Overall Sentiment
LivePerson	Neutral
Coeptis Therapeutics	Neutral

Coeptis Therapeutics has lower revenue, but higher earnings than LivePerson. Coeptis Therapeutics is trading at a lower price-to-earnings ratio than LivePerson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A
Coeptis Therapeutics	$1.36M	136.40	-$11.92M	-$1.63	N/A

79.8% of LivePerson shares are held by institutional investors. Comparatively, 13.9% of Coeptis Therapeutics shares are held by institutional investors. 2.0% of LivePerson shares are held by insiders. Comparatively, 24.3% of Coeptis Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

LivePerson has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Coeptis Therapeutics has a beta of -0.3, meaning that its stock price is 130% less volatile than the broader market.

Summary

LivePerson beats Coeptis Therapeutics on 7 of the 12 factors compared between the two stocks.

How does LivePerson compare to eGain?

eGain (NASDAQ:EGAN) and LivePerson (NASDAQ:LPSN) are both small-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

eGain has a net margin of 9.74% compared to LivePerson's net margin of -51.89%. eGain's return on equity of 11.75% beat LivePerson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
eGain	9.74%	11.75%	7.06%
LivePerson	-51.89%	N/A	-8.39%

In the previous week, eGain had 4 more articles in the media than LivePerson. MarketBeat recorded 4 mentions for eGain and 0 mentions for LivePerson. LivePerson's average media sentiment score of 0.00 beat eGain's score of -0.16 indicating that LivePerson is being referred to more favorably in the news media.

Company	Overall Sentiment
eGain	Neutral
LivePerson	Neutral

eGain has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market. Comparatively, LivePerson has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

eGain currently has a consensus price target of $6.50, indicating a potential upside of 8.88%. Given eGain's stronger consensus rating and higher possible upside, equities analysts clearly believe eGain is more favorable than LivePerson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
eGain	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

53.9% of eGain shares are owned by institutional investors. Comparatively, 79.8% of LivePerson shares are owned by institutional investors. 38.7% of eGain shares are owned by insiders. Comparatively, 2.0% of LivePerson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

eGain has higher earnings, but lower revenue than LivePerson. LivePerson is trading at a lower price-to-earnings ratio than eGain, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
eGain	$91.14M	1.71	$8.88M	$0.32	18.66
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A

Summary

eGain beats LivePerson on 11 of the 15 factors compared between the two stocks.

How does LivePerson compare to Bitventures?

LivePerson (NASDAQ:LPSN) and Bitventures (NASDAQ:BVC) are both small-cap technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

79.8% of LivePerson shares are owned by institutional investors. 2.0% of LivePerson shares are owned by company insiders. Comparatively, 84.6% of Bitventures shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Bitventures had 1 more articles in the media than LivePerson. MarketBeat recorded 1 mentions for Bitventures and 0 mentions for LivePerson. Bitventures' average media sentiment score of 1.32 beat LivePerson's score of 0.00 indicating that Bitventures is being referred to more favorably in the news media.

Company	Overall Sentiment
LivePerson	Neutral
Bitventures	Positive

Bitventures has a net margin of 0.00% compared to LivePerson's net margin of -51.89%.

Company	Net Margins	Return on Equity	Return on Assets
LivePerson	-51.89%	N/A	-8.39%
Bitventures	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivePerson	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bitventures	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LivePerson has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, Bitventures has a beta of -1.14, indicating that its stock price is 214% less volatile than the broader market.

Bitventures has lower revenue, but higher earnings than LivePerson.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivePerson	$228.89M	0.17	-$67.23M	-$13.74	N/A
Bitventures	$28.02M	3.34	-$5.37M	N/A	N/A

Summary

Bitventures beats LivePerson on 7 of the 10 factors compared between the two stocks.

Get LivePerson News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LPSN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LPSN vs. The Competition

Export

Metric	LivePerson	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$38.25M	$16.15B	$31.65B	$13.24B
Dividend Yield	N/A	3.43%	2.75%	15.89%
P/E Ratio	-0.23	143.81	81.35	26.05
Price / Sales	0.17	1,278.49	589.18	90.03
Price / Cash	0.58	45.13	49.13	51.25
Price / Book	-0.31	8.78	8.12	6.31
Net Income	-$67.23M	$431.57M	$702.36M	$361.43M
7 Day Performance	N/A	262.03%	114.88%	-1.67%
1 Month Performance	N/A	165.57%	74.29%	-3.94%
1 Year Performance	-58.67%	-0.50%	168.48%	2.77%

LivePerson Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LPSN LivePerson	0.1168 of 5 stars	$3.10 flat	N/A	N/A	$38.25M	$228.89M	N/A	1,540
TRAK ReposiTrak	0.8062 of 5 stars	$8.24 +0.6%	N/A	-47.0%	$148.84M	$22.61M	22.27	69	Earnings Report Gap Down
DVLT Datavault AI	3.0459 of 5 stars	$0.16 +6.0%	$2.50 +1,434.7%	-88.6%	$145.97M	$39.09M	N/A	194	Trending News
ZSQR Coeptis Therapeutics	0.1675 of 5 stars	$2.64 -1.5%	N/A	-76.3%	$142.04M	N/A	N/A	6
EGAN eGain	1.6246 of 5 stars	$5.77 +7.6%	$6.50 +12.7%	-32.7%	$140.28M	$91.14M	18.03	446

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LPSN) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LivePerson (LPSN) Competitors

LPSN vs. TRAK, DVLT, ZSQR, EGAN, and BVC

How does LivePerson compare to ReposiTrak?

Summary

How does LivePerson compare to Datavault AI?

Summary

How does LivePerson compare to Coeptis Therapeutics?

Summary

How does LivePerson compare to eGain?

Summary

How does LivePerson compare to Bitventures?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LPSN vs. The Competition

LivePerson Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LivePerson (LPSN) Competitors

LPSN vs. TRAK, DVLT, ZSQR, EGAN, and BVC

How does LivePerson compare to ReposiTrak?

Is TRAK or LPSN more profitable?

Do analysts prefer TRAK or LPSN?

Does the media favor TRAK or LPSN?

Do institutionals & insiders have more ownership in TRAK or LPSN?

Which has more volatility & risk, TRAK or LPSN?

Which has preferable earnings & valuation, TRAK or LPSN?

Summary

How does LivePerson compare to Datavault AI?

Does the media refer more to LPSN or DVLT?

Do insiders and institutionals believe in LPSN or DVLT?

Which has better valuation & earnings, LPSN or DVLT?

Which has more volatility & risk, LPSN or DVLT?

Do analysts recommend LPSN or DVLT?

Is LPSN or DVLT more profitable?

Summary

How does LivePerson compare to Coeptis Therapeutics?

Do analysts rate LPSN or ZSQR?

Is LPSN or ZSQR more profitable?

Does the media refer more to LPSN or ZSQR?

Which has higher valuation & earnings, LPSN or ZSQR?

Do institutionals and insiders believe in LPSN or ZSQR?

Which has more risk and volatility, LPSN or ZSQR?

Summary

How does LivePerson compare to eGain?

Is EGAN or LPSN more profitable?

Does the media favor EGAN or LPSN?

Which has more risk & volatility, EGAN or LPSN?

Do analysts rate EGAN or LPSN?

Do institutionals & insiders hold more shares of EGAN or LPSN?

Which has higher earnings and valuation, EGAN or LPSN?

Summary

How does LivePerson compare to Bitventures?

Do institutionals and insiders hold more shares of LPSN or BVC?

Does the media prefer LPSN or BVC?

Is LPSN or BVC more profitable?

Do analysts recommend LPSN or BVC?

Which has more volatility & risk, LPSN or BVC?

Which has better earnings and valuation, LPSN or BVC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LPSN vs. The Competition

LivePerson Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools